{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:11:25Z","timestamp":1722125485662},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.farma.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:00:21Z","timestamp":1719403221000},"page":"T164-T170","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Pharmaceutical care in respiratory diseases: Current situation and opportunities for hospital pharmacy in Spain"],"prefix":"10.1016","volume":"48","author":[{"given":"No\u00e9","family":"Garin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Zarate-Tamames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Jornet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Mar\u00eda","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Mar","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Del Estal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.farma.2024.05.010_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"Soriano","year":"2020","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.farma.2024.05.010_bb0010","series-title":"Espa\u00f1a en cifras 2019. Cat\u00e1logo de publicaciones oficiales de la Administraci\u00f3n General del Estado [Internet]","first-page":"1","author":"BOE","year":"2019"},{"issue":"6","key":"10.1016\/j.farma.2024.05.010_bb0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S2213-2600(20)30157-0","article-title":"Chronic respiratory diseases: a global view","volume":"8","author":"Labaki","year":"2020","journal-title":"Lancet Respir Med."},{"issue":"2","key":"10.1016\/j.farma.2024.05.010_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Systematic review of errors in inhaler use has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.farma.2024.05.010_bb0025","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2022.12.e7","article-title":"Evaluation of the techniques and steps of intranasal corticosteroid sprays administration","volume":"12","author":"Rattanawong","year":"2022","journal-title":"Asia Pac Allergy."},{"issue":"10","key":"10.1016\/j.farma.2024.05.010_bb0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","article-title":"Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD","volume":"107","author":"M\u00e4kel\u00e4","year":"2013","journal-title":"Respir Med."},{"key":"10.1016\/j.farma.2024.05.010_bb0035","series-title":"Pautes per a l'harmonitzaci\u00f3 del tractament farmacol\u00f2gic de la malaltia pulmonar obstructiva cr\u00f2nica","author":"Programa d'harmonitzaci\u00f3 farmacoterap\u00e8utica","year":"2018"},{"issue":"1","key":"10.1016\/j.farma.2024.05.010_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13223-021-00598-3","article-title":"Epidemiology of comorbidities and their association with asthma control","volume":"17","author":"Tomisa","year":"2021","journal-title":"Allergy Asthma Clin Immunol."},{"key":"10.1016\/j.farma.2024.05.010_bb0045","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/COPD.S111724","article-title":"Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease","volume":"11","author":"Camiciottoli","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"153","key":"10.1016\/j.farma.2024.05.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0044-2019","article-title":"Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue","volume":"28","author":"Caminati","year":"2019","journal-title":"Eur Respir Rev."},{"issue":"12","key":"10.1016\/j.farma.2024.05.010_bb0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med."},{"issue":"Suppl K","key":"10.1016\/j.farma.2024.05.010_bb0060","doi-asserted-by":"crossref","first-page":"K21","DOI":"10.1093\/eurheartj\/suz205","article-title":"The burden of comorbidities in pulmonary arterial hypertension","volume":"21","author":"Lang","year":"2019","journal-title":"Eur Heart J Suppl."},{"issue":"23","key":"10.1016\/j.farma.2024.05.010_bb0065","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/ajhp\/zxac243","article-title":"Board-certified pharmacy specialties: growth from 2008 to 2020 and projections to 2025","volume":"79","author":"Ignoffo","year":"2022","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.farma.2024.05.010_bb0070","series-title":"WHO Pharmacy-based asthma services","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.farma.2024.05.010_bb0075","unstructured":"The Pharmaceutical Society of Australia (PSA). The Respiratory Pharmacy Task Force: Key Objectives. Available from: The Pharmaceutical Society of Australia (PSA)."},{"issue":"2","key":"10.1016\/j.farma.2024.05.010_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3821\/145.2.cpj64","article-title":"A role for pharmacists in respiratory education","volume":"145","author":"Petrasko","year":"2012","journal-title":"Can Pharm J (Ott)."},{"issue":"1","key":"10.1016\/j.farma.2024.05.010_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.farma.2024.05.010_bb0095","article-title":"Adaptaci\u00f3n del Modelo de Atenci\u00f3n Farmac\u00e9utica CMO al Paciente con Patolog\u00edas Respiratorias","author":"Morillo","year":"2023","journal-title":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria"},{"key":"10.1016\/j.farma.2024.05.010_bb0100","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2147\/COPD.S383914","article-title":"Effectiveness of hospital pharmacist interventions for COPD patients: a systematic literature review and logic model","volume":"17","author":"Lin","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"4","key":"10.1016\/j.farma.2024.05.010_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18176\/jiaci.0488","article-title":"Multidisciplinary severe asthma management: the role of hospital pharmacists in accredited specialized adult asthma units in Spain","volume":"30","author":"Villama\u00f1\u00e1n","year":"2020","journal-title":"J Investig Allergol Clin Immunol."},{"issue":"1","key":"10.1016\/j.farma.2024.05.010_bb0110","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.sapharm.2020.03.027","article-title":"Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience","volume":"17","author":"Song","year":"2021","journal-title":"Res Social Adm Pharm."},{"issue":"2","key":"10.1016\/j.farma.2024.05.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1590\/s1679-45082018ao4112","article-title":"Pharmacotherapeutic follow-up in a respiratory intensive care unit: description and analysis of results","volume":"16","author":"Silva","year":"2018","journal-title":"Einstein (Sao Paulo)."},{"issue":"6","key":"10.1016\/j.farma.2024.05.010_bb0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11096-011-9577-z","article-title":"Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital","volume":"33","author":"Shen","year":"2011","journal-title":"Int J Clin Pharm."},{"issue":"23 Suppl 8","key":"10.1016\/j.farma.2024.05.010_bb0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2146\/ajhp080441","article-title":"Hospital pharmacists' role in the prevention and management of respiratory syncytial virus","volume":"65","author":"Robinson","year":"2008","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.farma.2024.05.010_bb0130","author":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria"},{"issue":"4","key":"10.1016\/j.farma.2024.05.010_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/pharmacy9040177","article-title":"Medicines optimisation for respiratory patients: the establishment of a new consultant respiratory pharmacist role in Northern Ireland","volume":"9","author":"Gormley","year":"2021","journal-title":"Pharmacy"},{"key":"10.1016\/j.farma.2024.05.010_bb0140","series-title":"Respiratory Pharmacists","author":"BTS Pharmacist Specialist Advisory Group","year":"2023"},{"key":"10.1016\/j.farma.2024.05.010_bb0145","author":"European Association of Hospital Pharmacy"},{"issue":"3","key":"10.1016\/j.farma.2024.05.010_bb0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/ph16030414","article-title":"Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis","volume":"16","author":"Garin","year":"2023","journal-title":"Pharmaceuticals"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634324000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:11:19Z","timestamp":1722060679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634324000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1130634324000904"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2024.05.010","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Pharmaceutical care in respiratory diseases: Current situation and opportunities for hospital pharmacy in Spain","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.02.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}